GS Hereditary Cancer Reporter¶
ACMG classification and clinical reporting for hereditary cancer-predisposition panels. Combines variant pathogenicity assessment with cancer-specific gene–disease evidence.
In development
This section is being authored. Contact your Intelliseq representative for the current details.